Coalition for Epidemic Preparedness Innovations

North America, District of Columbia, United States, Washington

Description

Coalition for Epidemic Preparedness Innovations (CEPI) is a non profit organisation.

Investor Profile

Coalition for Epidemic Preparedness Innovations has made 17 investments, with 7 in the past 12 months and 94% as lead.

Stage Focus

Grant (65%)
Post Ipo Equity (18%)
Undisclosed (6%)
Post Ipo Debt (6%)
Corporate Round (6%)

Country Focus

United States (41%)
South Africa (6%)
United Kingdom (6%)
France (6%)
Canada (6%)
Austria (6%)
Israel (6%)
Germany (6%)
China (6%)
Italy (6%)

Industry Focus

Biotechnology
Health Care
Pharmaceutical
Medical
Clinical Trials
Biopharma
Life Science
Therapeutics
Medical Device
Manufacturing

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Coalition for Epidemic Preparedness Innovations frequently co-invest with?

Bill & Melinda Gates Foundation

North America, New York, United States, New York

Co-Investments: 1

Horizon Europe

Europe, Zuid-Holland, The Netherlands, The Hague

Co-Investments: 1

What are some of recent deals done by Coalition for Epidemic Preparedness Innovations?

Gennova Biopharmaceuticals

Pune, Maharashtra, India

Gennova Biopharmaceuticals is a biotechnology company that develops biotherapeutics and provides product development programs.

BiopharmaBiotechnologyPharmaceutical

Corporate RoundMar 31, 2025

Amount Raised: $13,380,000

Fondazione Biotecnopolo di Siena

Siena, Toscana, Italy

Fondazione Biotecnopolo di Siena is a private non-profit foundation with registered office and operations to develop applied research.

GrantMar 19, 2025

Amount Raised: $4,500,000

Micron Biomedical

Atlanta, Georgia, United States

Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market.

BiopharmaBiotechnologyHealth CareWellness

GrantJan 8, 2025

Amount Raised: $3,700,000

Accumulus Synergy

Burlingame, California, United States

We are developing a global information exchange platform to accelerate the availability of safe and effective medicines.

Health CarePharmaceutical

GrantDec 10, 2024

Amount Raised: $19,100,000

Valneva

Saint-herblain, Pays de la Loire, France

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

BiotechnologyHealth CareMedicalTherapeutics

GrantJul 22, 2024

Amount Raised: $41,300,000

Apriori Bio

Boston, Massachusetts, United States

Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.

BiotechnologyClinical TrialsLife ScienceMedical

GrantJul 8, 2024

Amount Raised: $1,100,000

BioNTech

Mainz, Rheinland-Pfalz, Germany

BioNTech is a biopharmaceutical company that develops cancer therapeutics for infectious diseases.

BiopharmaBiotechnologyLife SciencePharmaceutical

Post Ipo EquityMay 29, 2024

Amount Raised: $145,000,000

aVaxziPen

Abingdon, Oxfordshire, United Kingdom

aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens.

BiotechnologyLife Science

UndisclosedJun 6, 2023

Amount Raised: $1,600,000

Aspen Pharmacare

Durban, NA - South Africa, South Africa

Aspen Pharmacare is a global supplier of branded and generic pharmaceutical products.

Health CareManufacturingMedical DevicePharmaceutical

GrantDec 12, 2022

Amount Raised: $30,000,000

Codiak Biosciences

San Francisco, California, United States

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

BiotechnologyMedicalTherapeutics

Post Ipo EquityJul 5, 2022

Amount Raised: $2,500,000